Chongqing Pharscin InnoBio Co., Ltd
—————
Focus on the development of small-molecule innovative drugs. Leveraging proprietary technology platforms like CAMDD and PROTAC, the company aims to develop Best-in-class and First-in-class therapeutics with significant clinical value.
We specialize in differentiated small-molecule drug discovery for major therapeutic areas, including oncology and autoimmune diseases. Driven by the goal of addressing unmet medical needs, Watson Inno is committed to developing novel medicines with fully independent global intellectual property rights.
R＆D pipeline (FIC＆BIC)
Focus on FIC & BIC Drug Development for Oncology and Autoimmune Diseases
Asset ORIP-1001 (Phase Ib): First RIPK1 Inhibitor for Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Computer Aided Multi-dimensional Drug Discovery (CAMDD)
Drug Research Institute
—————
Drug Research Institute - R&D Center for High-end Complex Formulations and Industrialization Technology Transfer
Patent Challenge and Circumvention Capability
Controlled-Release Formulation R&D Capability
Industrialization and Technology Transfer Capability
Oral Controlled-Release Platform
High-Difficulty BE Drug Technology Platform
Poorly Soluble Drug Solubilization Platform
Drug Quality Control Technology Platform
Soft Capsule Technology Platform
Chiral Drug Preparation Technology Platform
Reverse Engineering Technology Platform
FSMP (Food for Special Medical Purpose) Technology Platform
Testing Center
In 2021, the Testing Center of Pharscin Pharma was awarded the Laboratory Accreditation Certificate by CNAS becoming the first pharmaceutical company in Chongqing to achieve this recognition. Our testing results are mutually recognized in over 100 countries and regions worldwide, including the US, UK, Japan, and the EU. This ensures that the quality of Pharscin's products benchmarks against international standards, marking that the company has established a quality management system that meets advanced global standards.
CNAS Accreditation
Project Management
R&D Quality Management
Dual Filing in China and the US
know more>
know more>
know more>
know more>
Marketing HQ: No. 89, Middle Section of Huangshan Avenue, Liangjiang New Area, Chongqing
Production Base: Industrial Park, Rongchang District, Chongqing
TEL:029-67622999
FAX:023-67506555
Scan for more info
|
|